<DOC>
	<DOCNO>NCT02462005</DOCNO>
	<brief_summary>A total 250 patient all-comers patient population infrainguinal atherosclerotic disease implant schedule implant Ranger Drug coat balloon . Interim analysis carry every 50 subject enrol .</brief_summary>
	<brief_title>Treatment Femoro-popliteal Atherosclerotic Lesions Using Ranger Paclitaxel Coated Balloon Catheter . All Comers Registry .</brief_title>
	<detailed_description />
	<mesh_term>Paclitaxel</mesh_term>
	<criteria>Age â‰¥ 18 year . Patient must willing sign patient inform consent form . Patient de novo , restenotic reoccluded lesion infrainguinal .arteries implant schedule implant Ranger Drug coat balloon . Target vessel reference diameter 2.5 8 mm . Subjects pregnant plan become pregnant course study . Life expectancy less 1 year . Known allergy concomitant medication , contrast agent ( medically manage ) , antiplatelet , anticoagulant thrombolytic medication . Subject enrol another study reach primary endpoint time enrolment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>